Hanley Jr. Michael Conick - Net Worth and Insider Trading
Hanley Jr. Michael Conick Net Worth
The estimated net worth of Hanley Jr. Michael Conick is at least $50,955 dollars as of 2024-05-10. Hanley Jr. Michael Conick is the Chief Commercial Officer of Spyre Therapeutics Inc and owns about 1,448 shares of Spyre Therapeutics Inc (SYRE) stock worth over $50,955. Details can be seen in Hanley Jr. Michael Conick's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hanley Jr. Michael Conick has not made any transactions after 2022-06-08 and currently still holds the listed stock(s).
Transaction Summary of Hanley Jr. Michael Conick
Hanley Jr. Michael Conick Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hanley Jr. Michael Conick owns 1 companies in total, including Spyre Therapeutics Inc (SYRE) .
Click here to see the complete history of Hanley Jr. Michael Conick’s form 4 insider trades.
Insider Ownership Summary of Hanley Jr. Michael Conick
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRE | Spyre Therapeutics Inc | 2022-06-08 | Chief Commercial Officer |
Hanley Jr. Michael Conick Latest Holdings Summary
Hanley Jr. Michael Conick currently owns a total of 1 stock. Hanley Jr. Michael Conick owns 1,448 shares of Spyre Therapeutics Inc (SYRE) as of June 8, 2022, with a value of $50,955.
Latest Holdings of Hanley Jr. Michael Conick
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics Inc | 2022-06-08 | 1,448 | 35.19 | 50,955 |
Holding Weightings of Hanley Jr. Michael Conick
Hanley Jr. Michael Conick Form 4 Trading Tracker
According to the SEC Form 4 filings, Hanley Jr. Michael Conick has made a total of 1 transactions in Spyre Therapeutics Inc (SYRE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Spyre Therapeutics Inc is the acquisition of 1,128 shares on June 8, 2022, which cost Hanley Jr. Michael Conick around $20,022.
Insider Trading History of Hanley Jr. Michael Conick
- 1
Hanley Jr. Michael Conick Trading Performance
GuruFocus tracks the stock performance after each of Hanley Jr. Michael Conick's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hanley Jr. Michael Conick is -28.61%. GuruFocus also compares Hanley Jr. Michael Conick's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hanley Jr. Michael Conick within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hanley Jr. Michael Conick's insider trading performs compared to the benchmark.
Performance of Hanley Jr. Michael Conick
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.33 | | | | | |
| Relative Return to S&P 500(%) | -20.07 | | | | | |
Hanley Jr. Michael Conick Ownership Network
Hanley Jr. Michael Conick Owned Company Details
What does Spyre Therapeutics Inc do?
Who are the key executives at Spyre Therapeutics Inc?
Hanley Jr. Michael Conick is the Chief Commercial Officer of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .
Spyre Therapeutics Inc (SYRE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spyre Therapeutics Inc Insider Transactions
Hanley Jr. Michael Conick Mailing Address
Above is the net worth, insider trading, and ownership report for Hanley Jr. Michael Conick. You might contact Hanley Jr. Michael Conick via mailing address: C/o Aeglea Therapeutics, Inc., 901 S. Mopac Expressway, #250, Austin Tx 78746.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
